1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. GlaxoSmithKline Pharmaceuticals Limited
  6. News
  7. Summary
    500660   INE159A01016

GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

(500660)
  Report
End-of-day quote Bombay Stock Exchange  -  2022-06-30
1503.35 INR   +0.24%
06/29ANALYST RECOMMENDATIONS : HSBC, Oracle, McDonald's, Vodafone Group, Ferrari NV...
06/16GlaxoSmithkline Pharmaceuticals Limited Announces Resignation of Mark Dawson as Non- Executive Director
CI
06/14MARKETSCREENER'S WORLD PRESS REVIEW : June 14, 2022
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

GlaxoSmithKline Pharmaceuticals Sees Surge in Fiscal Q4 Consolidated Net Profit

05/17/2022 | 12:19am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 0.24% 1503.35 End-of-day quote.-14.61%
GSK PLC 1.13% 1785.6 Delayed Quote.11.14%
All news about GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
06/29ANALYST RECOMMENDATIONS : HSBC, Oracle, McDonald's, Vodafone Group, Ferrari NV...
06/16GlaxoSmithkline Pharmaceuticals Limited Announces Resignation of Mark Dawson as Non- Ex..
CI
06/14MARKETSCREENER'S WORLD PRESS REVIEW : June 14, 2022
05/31GLOBAL MARKETS LIVE : Credit Suisse, Telecom Italia, GSK, Apple, Boeing...
05/31MARKETSCREENER'S WORLD PRESS REVIEW : May 31, 2022
05/17GlaxoSmithKline Pharmaceuticals Limited announces results for the full year ended March..
AQ
05/17GlaxoSmithKline Pharmaceuticals Sees Surge in Fiscal Q4 Consolidated Net Profit
MT
05/16GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Manu Anand as Addition..
CI
05/16Glaxosmithkline Pharmaceuticals Limited Recommends Special Dividend for the Year Ended ..
CI
05/16GlaxoSmithKline Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31..
CI
More news
Analyst Recommendations on GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
More recommendations
Financials
Sales 2022 34 314 M 435 M 435 M
Net income 2022 11 084 M 140 M 140 M
Net cash 2022 9 694 M 123 M 123 M
P/E ratio 2022 24,3x
Yield 2022 1,82%
Capitalization 255 B 3 227 M 3 227 M
EV / Sales 2022 7,14x
EV / Sales 2023 6,75x
Nbr of Employees 3 840
Free-Float 24,5%
Chart GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Duration : Period :
GlaxoSmithKline Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 1 503,35 INR
Average target price 1 653,33 INR
Spread / Average Target 9,98%
EPS Revisions
Managers and Directors
Sridhar Venkatesh Managing Director & Director
Juby Chandy Chief Financial Officer & Director
Renu Sud Karnad Non-Executive Chairman
Priyanka Bhatia Head-Medical Affairs
Ajay A. Nadkarni Secretary & Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-14.61%3 227
JOHNSON & JOHNSON3.76%472 389
PFIZER, INC.-11.21%293 506
ELI LILLY AND COMPANY17.38%292 291
ROCHE HOLDING AG-15.48%272 104
ABBVIE INC.13.59%271 782